CorMedix, Inc. (CRMD)
7.03
-0.05
(-0.71%)
USD |
NASDAQ |
Feb 20, 16:00
6.975
-0.06
(-0.78%)
Pre-Market: 08:43
CorMedix Market Cap : 553.89M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 151.52B |
| Amicus Therapeutics, Inc. | 4.499B |
| Arcutis Biotherapeutics, Inc. | 3.113B |
| ANI Pharmaceuticals, Inc. | 1.747B |
| Castle Biosciences, Inc. | 852.60M |
Market Cap Related Metrics
| PE Ratio | 3.424 |
| PS Ratio | 2.367 |
| Price to Book Value | 1.480 |
| Price to Free Cash Flow | 6.816 |
| Price | 7.03 |
| Earnings Yield | 29.20% |
| Operating PE Ratio | 4.880 |
| Normalized PE Ratio | 3.434 |